Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthNUTX -1.32%75 EBIT per Share is $51.05 as of Jun. 2026. GuruFocus rates NUTX with a GF Score™ of 75/100 and a GF Value™ of $82.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 523 Healthcare Providers & Services companies, Nutex Health ranks worse than 191204.4% on this metric.
Nutex Health's EBIT per Share for the
three
months ended in Jun. 2026 was $17.34.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $51.05.
During the past 12 months, the average EBIT per Share Growth Rate of Nutex Health was 41.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nutex Health's EBIT per Share or its related term are showing as below:
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Nutex Health was -14.80% per year. The lowest was -14.80% per year. And the median was -14.80% per year.
NUTX's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.8 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Nutex Health's EBIT for the
three
months ended in Jun. 2026 was $121.8 Mil.
Nutex Health (NAS:NUTX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nutex Health EBIT per Share Related Terms
Nutex Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nutex Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $51.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutex Health (NUTX) has a EBIT per Share of $51.05 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nutex Health and its competitors. According to the industry distribution chart, Nutex Health ranks #999999 out of 523 companies in the Healthcare Providers & Services industry.
Is Nutex Health's EBIT per Share too high?
Nutex Health's current EBIT per Share is $51.05. The Healthcare Providers & Services industry median EBIT per Share is 11.80. Nutex Health's value of $51.05 is 332.6% above this industry median. Based on the distribution chart, Nutex Health ranks #999999 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nutex Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's EBIT per Share compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #999999 out of 523 companies for EBIT per Share. This places Nutex Health in the lower half of its industry. The industry median EBIT per Share is 11.80. Nutex Health's value of $51.05 is 332.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current EBIT per Share of $51.05 is 332.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nutex Health and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current EBIT per Share is $51.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (NUTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $82.60, compared to a current price of $191.34 — trading 131.6% above its estimated fair value. The current EBIT per Share is $51.05 and 332.6% above the Healthcare Providers & Services industry median of 11.80. Nutex Health's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nutex Health (NUTX), the current EBIT per Share is $51.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (NUTX) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of $191.34 is trading 131.6% above its estimated GF Value™ of $82.60.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for NUTX:
EBIT per Share: $51.05
GF Value™: $82.60 vs. price of $191.34 (131.6% above fair value)
Industry Position: 332.6% above the Healthcare Providers & Services median (#999999 of 523)
No single metric tells the full story. See the NUTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
75GF Score
Get the complete analysis for NUTX
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUTX has been successfully added to your 
